(S, R)-LSN 3318839

CAS No. 2765539-92-0

(S, R)-LSN 3318839( —— )

Catalog No. M35704 CAS No. 2765539-92-0

(S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 409 In Stock
10MG 604 In Stock
25MG 938 In Stock
50MG 1265 In Stock
100MG 1702 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (S, R)-LSN 3318839
  • Note
    Research use only, not for human use.
  • Brief Description
    (S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.
  • Description
    (S, R)-LSN 3318839 is an allosteric modulator of the glucagon-like peptide-3318839 receptor (GLP-1R) that has demonstrated powerful hypoglycemic effects in animal models alone or in combination with sitagliptin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    Glucagon Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2765539-92-0
  • Formula Weight
    480.39
  • Molecular Formula
    C26H23Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](C)(N1C=2C(N=C1)=CN=C(C2)C3=C([C@@H](C(O)=O)C)C=CC=C3)C4=C(Cl)C(=CC=C4Cl)C5CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Semaglutide

    Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.

  • GLP-1R modulator C5

    GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes.

  • HAEGT

    HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.